ENTRY       D10058                      Drug
NAME        Solanezumab (USAN/INN);
            Solanezumab (genetical recombination) (JAN)
FORMULA     C6396H9922N1712O1996S42
EXACT_MASS  143993.5792
MOL_WEIGHT  144082.2207
SEQUENCE    (Heavy chain)
            EVQLVESGGG LVQPGGSLRL SCAASGFTFS RYSMSWVRQA PGKGLELVAQ INSVGNSTYY
            PDTVKGRFTI SRDNAKNTLY LQMNSLRAED TAVYYCASGD YWGQGTLVTV SSASTKGPSV
            FPLAPSSKST SGGTAALGCL VKDYFPEPVT VSWNSGALTS GVHTFPAVLQ SSGLYSLSSV
            VTVPSSSLGT QTYICNVNHK PSNTKVDKKV EPKSCDKTHT CPPCPAPELL GGPSVFLFPP
            KPKDTLMISR TPEVTCVVVD VSHEDPEVKF NWYVDGVEVH NAKTKPREEQ YNSTYRVVSV
            LTVLHQDWLN GKEYKCKVSN KALPAPIEKT ISKAKGQPRE PQVYTLPPSR DELTKNQVSL
            TCLVKGFYPS DIAVEWESNG QPENNYKTTP PVLDSDGSFF LYSKLTVDKS RWQQGNVFSC
            SVMHEALHNH YTQKSLSLSP G
            (Light chain)
            DVVMTQSPLS LPVTLGQPAS ISCRSSQSLI YSDGNAYLHW FLQKPGQSPR LLIYKVSNRF
            SGVPDRFSGS GSGTDFTLKI SRVEAEDVGV YYCSQSTHVP WTFGQGTKVE IKRTVAAPSV
            FIFPPSDEQL KSGTASVVCL LNNFYPREAK VQWKVDNALQ SGNSQESVTE QDSKDSTYSL
            SSTLTLSKAD YEKHKVYACE VTHQGLSSPV TKSFNRGEC
            (Disulfide bridge: H22-H96, H139-H195, H215-L219, H221-H'221, H224-H'224, H256-H316, H362-H420, H'22-H'96, H'139-H'195, H'215-L'219, H'256-H'316, H'362-H'420, L23-L93, L139-L199, L'23-L'93, L'139-L'199)
  TYPE      Peptide
EFFICACY    Dementia therapeutic agent
  TYPE      Monoclonal antibody
COMMENT     Alzheimer's disease
TARGET      Amyloid beta [CPD:C16514 C16515]
STR_MAP     map07056  Agents for Alzheimer-type dementia
DBLINKS     CAS: 955085-14-0
            PubChem: 135626778
///
